AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,529,133 | -38.4% | 582,900 | -23.3% | 0.01% | -36.8% |
| Q2 2023 | $7,357,768 | +132.9% | 760,100 | +163.6% | 0.02% | +137.5% |
| Q1 2023 | $3,159,768 | +823.5% | 288,300 | +264.0% | 0.01% | +700.0% |
| Q4 2022 | $342,144 | -29.2% | 79,200 | +23.4% | 0.00% | 0.0% |
| Q3 2022 | $483,000 | -42.3% | 64,200 | +13.0% | 0.00% | -50.0% |
| Q3 2020 | $837,000 | -40.9% | 56,800 | -34.9% | 0.00% | -50.0% |
| Q2 2020 | $1,417,000 | +32.3% | 87,200 | +18.2% | 0.00% | 0.0% |
| Q1 2020 | $1,071,000 | +1408.5% | 73,800 | +577.1% | 0.00% | – |
| Q1 2019 | $71,000 | -51.4% | 10,900 | -57.9% | 0.00% | – |
| Q2 2018 | $146,000 | -25.9% | 25,900 | -31.7% | 0.00% | -100.0% |
| Q1 2018 | $197,000 | -10.0% | 37,900 | -21.7% | 0.00% | 0.0% |
| Q4 2017 | $219,000 | -37.1% | 48,400 | -12.8% | 0.00% | 0.0% |
| Q3 2017 | $348,000 | +21.7% | 55,500 | +19.1% | 0.00% | 0.0% |
| Q2 2017 | $286,000 | – | 46,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 230,000 | $993,600 | 1.92% |
| AlphaCentric Advisors LLC | 352,500 | $1,522,800 | 1.50% |
| NEA Management Company, LLC | 3,969,834 | $17,149,683 | 0.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 573,530 | $2,477,650 | 0.76% |
| ARMISTICE CAPITAL, LLC | 5,000,000 | $21,600,000 | 0.38% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 93,658 | $404,603 | 0.27% |
| Artal Group S.A. | 1,000,000 | $4,320 | 0.24% |
| Virtus ETF Advisers LLC | 64,786 | $279,876 | 0.15% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $864,000 | 0.13% |
| HighMark Wealth Management LLC | 37,499 | $161,996 | 0.12% |